Eli Lilly sues over knockoffs of signature weight loss drug, Zepbound
Eli Lilly sued three medical spas and online vendors for selling products that claim to contain the ingredient in its weight-loss medicine Zepbound.
FDA says this weight loss drug shortage is over, but patients worry about cost and availability
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.
Weight-Loss Drugs May Help Alcohol and Opioid Addiction
Research hints that medications like Zepbound and Wegovy could provide new ways to treat opioid and alcohol abuse.
Is Eli Lilly Still a Top Healthcare Stock After Its Blockbuster Drug Approval?
Pharmaceutical giant Eli Lilly and Company (LLY) is on an impressive run after winning Food and Drug Administration approval for a new eczema drug called Ebglyss. As the company expands its reach in the diabetes,
FDA Backtracks; Pharmacies Continue With Knockoff Weight Loss Drugs
The Washington Post reports that intense public backlash and a lawsuit led the FDA to reconsider its declaration, made two weeks ago, that the shortage of weight-loss drugs Mounjaro and Zepbound is over.
MangoRx hits back at Eli Lilly’s weight loss drug copycat claims
MangoRx was responding to Eli Lily after the drugmaker sued it and two other medical spas and online vendors earlier this week for selling products claiming to contain tirzepatide
ConsumerAffairs7d
Compounding pharmacies can keep making Mounjaro and Zepbound copies
The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...
Fast Company14d
Why Ozempic, Zepbound, and other weight-loss drug dupes carry risks
To combat these alternative sellers, pharmaceutical company Eli Lilly began offering an alternative version of its brand-name ...
Wegovy and Zepbound rival targeting ‘next generation' of obesity drugs, Zealand Pharma CEO says
Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market ...
BioPharma Dive9d
FDA, facing pressure, to review position on Zepbound, Mounjaro shortage
The agency agreed in court to allow compounding companies to continue producing copycat versions of Lilly’s fast-selling medicines while it reevaluates its recent decision to declare the drugs back in ...
UPI6d
Wegovy, other weight-loss drugs might help with alcoholism, opioid addiction
Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid addiction, a new study finds. People taking this class of drugs ...
Medical News Today24d
How to Get Zepbound in 2024
If you buy through links on this page, we may earn a small commission. Here’s our process. Zepbound (tirzepatide) is an injectable drug for weight loss in those with obesity or those with ...
The Washington Post4d
Amid backlash, FDA changes course over shortage of weight-loss drugs
The U.S. Food and Drug Administration, after intense public pressure and a lawsuit, is reconsidering its declaration barely two weeks ago that a shortage of the appetite-suppressing drugs Mounjaro ...
Shady drugmaker sold DIY weight-loss drug marked for animal use, suit alleges
Amid ongoing legal battles over coveted GLP-1 therapies, a drug vendor in Washington state is accused of running an ...